Endothelium-dependent and -independent functions are impaired in patients with coronary heart disease

Atherosclerosis

Volumn 149, Issue 1, 2000, Pages 19-24

  Zhang, Xiang Yu ^a   Zhao, Shui Ping ^a   Li, Xiang Ping ^a   Gao, Mei ^a   Zhou, Qi Chang ^a  

^a Second Affil Hosp   (China)

Author keywords

Atherosclerosis; CHD; Endothelium; Hypertension

Indexed keywords

GLYCERYL TRINITRATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; ISCHEMIC HEART DISEASE; LIPOPROTEIN DEFICIENCY; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; VASODILATATION;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTERIOSCLEROSIS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY DISEASE; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REFERENCE VALUES; RISK ASSESSMENT; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 0033995226     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00288-9     Document Type: Article

References (34)

1. Myers P.R., AI-Swayeh O.A., Chone N.W.S., Bates J.N., Harrison D.G. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. Nature. 345:1990;161-163.
2. Mehta J.L. Endothelium, coronary vasodilation, and organic nitrates. Am Heart J. 129:1995;382-391.
3. Zeiher A.M., Drexler H., Wollschlager H., Juet H. Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation. 89:1991;391-401.
4. Celermajer D.S., Sorensen K.E., Gooch V.M., Spiegelhalter D.J., Miller O.I., Sullivan I.D., Lloyd J.K., Deanfield L.E. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 340:1992;1111-1115.
5. Anderson T.J., Uehata A., Gerhard M.D., Meredith L.T., Knab S., Delagrange D., Lieberman E.H., Ganz P., Creager M.A., Yeung A.C., Selwyn A.P. Close correlation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol. 26:1995;1235-1241.
6. Celermajer D.S., Sorensen K.E., Bull C., Robinson J., Deanfield J.E. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol. 24:1994;1468-1474.
7. Sorensen K.E., Kristensen I.B., Celermajer D.S. Atherosclerosis in the human brachial artery. J Am Coll Cardiol. 29:1997;318-322.
8. Lieberman E.H., Uehata A., Polak J. Flow-mediated vasodilation is impaired in the brachial artery of patients with coronary artery disease or with diabetes mellitus (abstract). Clin Res. 41:1993;217A.
9. Corretti M.C., Plotnick G.D., Vogel R.A. Technical aspects of evaluating brachial artery vasodilation using high-frequency ultrasound. Am J Physiol. 268:1995;H1397-H1404.
10. Li J., Zhao S.P., Li X.P., Zhuo Q.C., Gao M., Lu S.-K. Non-invasive detection of endothelial dysfunction in patients with essential hypertension. Int J Cardiol. 61:1997;165-169.
11. Celermajer D.S., Sorensen K.E., Spiegelhalter D.J., Georgakopoulos D., Robinson J., Deanfield J.E. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol. 24:1994;471-476.
12. Zeiher A.M., Schachingerr V., Minners J. Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function. Circulation. 92:1995;1094-1100.
13. Liyama K., Nagano M., Yo Y., Nagano N., Kamide K., Higaki J., Mikami H., Ogihara T. Impaired endothelial function with essential hypertension assessed by ultrasonography. Am Heart J. 132:1996;779-782.
14. Schachinger V., Zeiher A.M. Quantitative assessment of coronary vasoreactivity in humans in vivo. Importance of baseline vasomotor tone in atherosclerosis. Circulation. 92:1995;2087-2094.
15. Adams M.R., Robinson J., Mccredie R., Paul Seale J., Sorensen K.E., Deanfield J.P., Celermajer D.S. Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilation in adults at risk of atherosclerosis. J Am Coll Cardiol. 32:1998;123-127.
16. Lee R.T., Kamm R.D. Vascular mechanics for the cardiologist. J Am Coll Cardiol. 23:1994;1289-1295.
17. Gibbon G.H., Dzau V.J. The emerging concept of vascular remolding. New Engl J Med. 330:1994;1431-1438.
18. Mugge A., Elwell J.H., Peterson T.E., Hofmeyer T.G., Heistad D.D., Harrison D.G. Chronic treatment with polyethylene-glycolated superoxide dismutase partially restores endothelium-dependent vascular relaxations in cholesterol-fed rabbits. Circ Res. 69:1991;1293-1300.
19. Laursen J.B., Boesgaard S., Poulsen H.E., Aldershvile J. Nitrate tolerance impairs nitric oxide-mediated vasodilation in vivo. Cardiovasc Res. 31:1996;814-819.
20. Parker JO and the Isosorbide-5-Mononitrate Study Group. Eccentric dosing with isosorbide-5 mononitrate in angina pectoris. Am J Cardiol 1993;73:871-76.
21. Packer M., Lee W.H., Kessler P.D., Gottlieb S.S., Medina N., Yushak M. Prevention and reversal of nitrate tolerance in patients with congestive heart failure. New Engl J Med. 317:1987;799-804.
22. Jessup W. Oxidized lipoproteins and nitric oxide. Curr Opin Lipidol. 7:1996;274-280.
23. Cox D.A., Cohen M.L. Effects of oxidized low-density lipoprotein on vascular contraction and relaxation: clinical and pharmacological implication in atherosclerosis. Pharmacol Rev. 49:1996;3-19.
24. Chen L.Y., Mehta P., Mehta J.L. Ox-LDL decreases L-arginine uptake and nitric oxide synthase protein expression in human platelets. Circulation. 93:1996;1740-1746.
25. Liao J.K., Shin W.S., Lee W.Y., Clark S.L. Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. J Biol Chem. 270:1995;319-324.
26. Simon B.C., Cunningham L.D., Cohen R.A. Oxidized low density lipoproteins cause contraction and inhibit relaxation in the pig coronary artery. J Clin Invest. 86:1990;75-79.
27. Levin G.N., Frei B., Koulouris S.N., Gerbard M.D., Keaney J.F., Vita J.A. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery diseases. Circulation. 93:1996;1107-1113.
28. Jorge P.A.R., Osaki M.R., Almeida E.D., Neto L.C., Metze K. Effects of vitamin E on endothelium-dependent coronary flow in hypercholesterolemic dogs. Arherosclerosis. 126:1996;43-51.
29. Aoyama T., Yui Y., Morishita H., Kawai C. Prostaglandin I2 half-life regulated by high density lipoprotein is decreased in acute myocardial infarction and unstable angina pectoris. Circulation. 81:1990;1784-1791.
30. Parthasarathy S., Barnett J., Fong L.G. High-density lipoprotein inhibits the oxidative modification of low -density lipoprotein. Biochim Biophys Acta. 1044:1990;275-283.
31. Kuhn F.E., Mohler E.R., Satler L.F., Reagan K., Lu D.Y., Rackley C.E. Effects of high-density lipoprotein on acetylcholine-induced coronary vasoreactivity. Am J Cardiol. 68:1991;1425-1430.
32. Zeiher A.M., Schachinger V., Hohnloser S.H., Saurbier B., Just H. Coronary atherosclerotic wall thickening and vascular reactivity in humans. Elevated high-density lipoprotein levels ameliorate abnormal vasoconstriction in early atherosclerosis. Circulation. 89:1994;2525-2532.
33. Kannel W.B. CHD risk factors: a Framingham study update. Hosp Pract. 15:1990;93-104.
34. StamSalvini S., Willett W.C., Hennekens C.H., Pfer M.J., Sacks F.M. A prospective study of cholesterol, apolipoprotein, and the risk of MI. New Engl J Med. 325:1991;373-381.